APA

Martins H. R., Silva R. M., Valadares H. M. S., Toledo M. J. O., Veloso V. M., Vitelli-Avelar D. M., Carneiro C. M., Machado-Coelho G. L. L., Bahia M. T., Martins-Filho O. A., Macedo A. M. & Lana M. (20080108). Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. : Antimicrobial agents and chemotherapy.

Chicago

Martins H R, Silva R Moreira, Valadares H M S, Toledo M J O, Veloso V M, Vitelli-Avelar D M, Carneiro C M, Machado-Coelho G L L, Bahia M T, Martins-Filho O A, Macedo A M and Lana M. 20080108. Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. : Antimicrobial agents and chemotherapy.

Harvard

Martins H. R., Silva R. M., Valadares H. M. S., Toledo M. J. O., Veloso V. M., Vitelli-Avelar D. M., Carneiro C. M., Machado-Coelho G. L. L., Bahia M. T., Martins-Filho O. A., Macedo A. M. and Lana M. (20080108). Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. : Antimicrobial agents and chemotherapy.

MLA

Martins H R, Silva R Moreira, Valadares H M S, Toledo M J O, Veloso V M, Vitelli-Avelar D M, Carneiro C M, Machado-Coelho G L L, Bahia M T, Martins-Filho O A, Macedo A M and Lana M. Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. : Antimicrobial agents and chemotherapy. 20080108.